Clinical Trials Browser

NCT07078604 2026-04-07

A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer

Phase 2 Recruiting

20 enrolled

Breast

Triple Negative Breast Neoplasms

NCT05143970 2026-03-20

CHANCES

Phase 1 Recruiting

27 enrolled

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT03424005 2026-03-16

Morpheus-panBC

Phase 1/2 Recruiting

792 enrolled

Breast

Breast Neoplasms

NCT04703244 2026-03-03

Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer

Recruiting

999 enrolled

Breast

Breast Neoplasms

NCT07342283 2026-03-02

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer

Phase 2 Recruiting

30 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06627712 2026-01-30

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

Phase 3 Recruiting

318 enrolled

Breast

Triple Negative Breast Neoplasms

NCT05909332 2026-01-21

Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)

Phase 3 Recruiting

764 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06596018 2025-12-30

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

Phase 1/2 Recruiting

96 enrolled

Breast

Breast Neoplasms

NCT06195709 2025-12-18

ECLECTIC

Phase 3 Recruiting

300 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT06635980 2025-12-12

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Phase 2 Recruiting

120 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05076682 2025-12-03

Renaissance

Phase 2 Recruiting

80 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06731140 2025-11-17

Resilire

Phase 2 Recruiting

10 enrolled

Breast

HER2 Negative Breast Cancer

NCT07137793 2025-08-22

PTX / BC

Phase 2 Recruiting

46 enrolled

Breast

Breast Neoplasms

NCT07108309 2025-08-07

AREAL

Phase 2 Recruiting

124 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07104266 2025-08-05

Triple Negative Breast Cancer and Celecoxib. Pilot Study

Phase 2 Recruiting

30 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07096180 2025-07-31

Clinical Observational Studies:Integrative TCM and Western Medicine for Breast Cancer

Recruiting

200 enrolled

Breast

Breast Neoplasms

NCT06678048 2025-06-06

Arsenous Acid for Refractory Triple-Negative Breast Cancer

Phase 2 Recruiting

12 enrolled

Breast

Breast Neoplasms

NCT06642441 2025-01-17

Effect of Vitamin D Supplementation on Chemotherapy Side Effects After Adjuvant Chemotherapy for Breast Cancer

Phase NA Recruiting

100 enrolled

Breast

Breast Neoplasms

NCT03755739 2024-06-25

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Phase 2/3 Recruiting

200 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms

NCT06341621 2024-04-10